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Sensorineural hearing loss (SNHL) is caused by an irreversible impairment of cochlear
hair cells and subsequent progressive degeneration of spiral ganglion neurons (SGNs).
Eighty-five requiring 3 (Efr3) is a plasma membrane protein conserved from yeast to
human, and knockout of Efr3a was reported to facilitate the survival of hippocampal
newborn neurons in adult mice. Previously, we found Efr3a expression in the auditory
neural pathway is upregulated soon after the destruction of hair cells. Here we
conducted a time-course analysis of drug-caused damage to hearing ability, hair cells
and SGNs in Efr3a knocking down mice (Efr3a−/+, Efr3a KD) and their wild type
littermates. Functional examination showed that both groups of mice suffered from
serious hearing loss with a higher level of severity in wild type (WT) mice. Morphologic
observation following drugs administration showed that both WT and Efr3a KD mice
went through progressive loss of hair cells and SGNs, in association with degenerative
changes in the perikarya, intracellular organelles, cell body conformation in SGNs, and
the changes of SGNs in WT mice were more severe than in Efr3a KD mice. These
beneficial effects of Efr3a KD could be ascribed to an increase in the expression of some
neurotrophic factors and their receptors in Efr3a KD mice. Our results indicate that Efr3a
insufficiency suppresses drug-caused SNHL neurodegeneration in association with an
increase in the expression of some neurotrophic factors and their receptors, which may
be targeted in the treatment of neurodegeneration.
Keywords: hearing loss, Efr3a, spiral ganglion neuron, degeneration, neurotrophic factors
Abbreviations: ABR, auditory brainstem response; BDNF, brain-derived neurotrophic factor; EDTA, Ethylene
Diamine Tetraacetic Acid; Efr3, Eighty-five requiring 3; Efr3a KD, Efr3a knocking down; IHCs, inner hair
cells; NGF, neural growth factor; NT-3, neurotrophins-3; OHCs, outer hair cells; PCR, polymerase chain
reaction; PI4P, phosphoinositol-4-phosphate; RBO, rolling blackout; RT-PCR, reverse transcription PCR; SGN, spiral
ganglion neuron; SNHL, sensorineural hearing loss; TEM, transmission electron microscope; TrkA, tyrosine
kinase receptor A; TrkB, tyrosine kinase receptor B; TrkC, tyrosine kinase receptor C; WT mice, wild
type mice.
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INTRODUCTION
The majority of the deafness patients suffer from sensorineural
hearing loss (SNHL). SNHL, resulting from noise exposure,
aging, genetic deficiency or ototoxic drugs, is characterized by
the irreversible damage of cochlear hair cells followed by a
progressive degeneration of spiral ganglion neurons (SGNs) and
auditory nerve fibers (Webster and Webster, 1981; Lawner et al.,
1997; Hardie and Shepherd, 1999; Fetoni et al., 2013). SGNs are
the primary bipolar neurons indispensable to the pathway of
auditory system that relays auditory information from the hair
cells to the auditory center (Martinez-Monedero et al., 2006;
Richardson et al., 2006).
In humans or other mammals, the loss of the cochlear
hair cells cause permanent hearing impairment for its inability
to regenerate. Cochlear implantation technology is the major
option to treat hearing impairment due to the loss of cochlear
hair cells, of which the efficacy depends on the number of
surviving functional SGN (Nadol et al., 1989; Gantz et al.,
1993; Xu et al., 2012). Therefore, the current primary strategy
to further advances in cochlear implantation is to preserve
SGN and induce SGN regeneration to maximize the number
of functional neurons. Recently, some research progress has
been made in repairing damaged SGN and regeneration of
cochlear nerve fiber, such as via stem cell transplantation or
exogenous neurotrophic factor (Agterberg et al., 2008; Jang
et al., 2015). But there are relatively less studies about blocking
or alleviating the degeneration of SGN and their synaptic
terminal.
After noise, antibiotic or toxic insult to the cochlea, synapses
between peripheral nerve fibers of the SGN and the hair cells in
the cochlea are the first to degenerate, followed by the swollen
or retraction of the cochlear nerve fiber over various time
periods and finally dysfunction and loss of SGN (Dodson and
Mohuiddin, 2000; Agterberg et al., 2008; Kujawa and Liberman,
2009; Nie et al., 2015). However, the molecular mechanism
for the retrograde degeneration of SGN is unclear. Dying
back is a common and chronic pathological process of neural
degeneration which arises gradually from distal to proximal and
is found in a wide variety of degenerative and toxic conditions of
the peripheral and central nervous system in neurodegenerative
disorders, and several possibilities have been suggested and
tested to explain the dying back, involving undernourishment
of the distal axon, impairment of axonal transport of organelles
and vesicles, target-derived neurotrophic factors (Fischer et al.,
2004; Dadon-Nachum et al., 2011). In the SNHL, retrograde
degeneration of SGN subsequent to the hair cell loss in the
cochlea is morphologically similar to ‘‘dying back’’, but the
molecular mechanism is largely unknown.
The yeast Eighty-five requiring 3 (Efr3) gene, and its
Drosophila and mammalian homologs, rolling blackout (rbo) and
Efr3a/Efr3b respectively, encode a membrane-localized protein
that forms a protein complex with another two proteins on
the plasma membrane to maintain the plasmalemmal level of
phosphoinositol-4-phosphate (PI4P) and PI4,5P (Huang et al.,
2004; Baird et al., 2008; Hammond et al., 2012; Nakatsu et al.,
2012), which have widely direct functions in the sensory and
motor nervous system, including production of IP3 and DAG,
regulation of signal transduction, exocytosis, endocytosis, ion
channel and neurotransmitter receptor functions, cell adhesion,
and nucleation of the actin cytoskeleton (Di Paolo and De
Camilli, 2006). The endocytosis mediated by PI4,5P is involved
in a variety of processes at the cell surface (Kumari et al., 2010;
McMahon and Boucrot, 2011), including axonal and neuronal
degeneration, collapse, disintegration and death (Weinkove et al.,
2008; Kuboyama et al., 2015). In Drosophila, the RBO played
a pivotal role in PI4,5P-mediated signaling in photoreceptors,
and in bulk endocytosis and macropinocytosis in neuronal and
non-neuronal cells (Huang et al., 2004, 2006; Vijayakrishnan
et al., 2009). In mammalian cells, Efr3 is also important in
the control of G-protein-coupled receptor (GPCR)-mediated
signaling by affecting the phosphorylation of GPCR (Bojjireddy
et al., 2015). In adult mice, Efr3 plays an important role in the
survival of newborn hippocampal neurons possibly via regulating
the brain-derived neurotrophic factor (BDNF) pathway (Qian
et al., 2017). Moreover, in rodents, Efr3a expression in the
medial olivocochlear neurons in the brain stem and in the
cochlear SGNs is up-regulated soon after the destruction of
hair cells (Munemoto et al., 2004; Nie et al., 2015), suggesting
a role of Efr3a in the auditory remodeling or degeneration
subsequent to the deprivation of acoustic signal. In addition,
we previously showed that the expression of Efr3a in the
cochlear SGNs was increased mainly at the early stage of
SGNs degeneration, which indicated that Efr3a may play an
intermediary role in initiating cochlear SGNs degeneration (Nie
et al., 2015).
In this study, we investigated the effect of partial knockout of
Efr3a on the hair cells loss, SGN degeneration and hearing loss
caused by kanamycin and furosemide treatment, and found that
Efr3a insufficiency attenuates the progressive SGN degeneration.
It is known that SGN degeneration during hearing loss could
be alleviated by the treatment with neurotrophic factors, such
as BDNF or neurotrophins-3 (NT-3) (Staecker et al., 1996;
Richardson et al., 2005; Shepherd et al., 2005; Agterberg et al.,
2008). We further examined the effect of Efr3a insufficiency
on the expression levels of several neurotrophic factors and
their receptors, and found some were elevated. Thus, our
results show that Efr3a insufficiency attenuates drug-caused SGN
degeneration possibly by up-regulating some neurotrophins-
mediated signalings.
MATERIALS AND METHODS
Generation of Efr3a−/+ Mutant Mice
Efr3a were generated by breeding Efr3afl/fl mice (Qian et al.,
2017) to Ella-Cre mice, which expresses efficient Cre activity in
one-cell zygote stage of embryonic development (Lakso et al.,
1996). The progenies with the second exon of Efr3a deleted and a
reading frame shift in Efr3amRNA (Efr3a−/+) were backcrossed
to C57BL/6 mice for over 10 generations to obtain genetic
background-purified Efr3a−/+ mice.
All animals were raised under standard laboratory conditions
with food and water freely available. Humidity and temperature
were kept constant at 60 ± 5% and 24 ± 2◦C, respectively.
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Lights were on between 7:00 am and 7:00 pm. The care and
process of animals were complied with the approval of the
Institutional Authority for Laboratory Animal Care of Xinhua
Hospital Affiliated Shanghai Jiao Tong University School of
Medicine (Shanghai, China).
Genotype and Efr3a Protein Analysis
Genotypes were determined by polymerase chain reaction
(PCR) using genomic DNA from mouse tails. The
mutant Efr3a−/+ allele was detected using primer F
5′-TTATTTAGTATGTTGGACGA G-3′ and primer R
5′-ACAAACTTAACCTCCATGTT-3′. A 500 bp band was
detected in mice with Efr3a−/+ (Efr3a knocking down mice,
Efr3a KD mice), while no signal was examined in wild type mice
(WT mice; data not shown).
Efr3a protein level was determined by fluorescent
immunohistochemistry and western blotting, and the detail
method referred to the previously report (Nie et al., 2015). For
fluorescent immunohistochemistry, the cochleae of 8 weeks
old mice without any treatment were isolated, and dealt with
decalcification and dehydration. Then frozen sections (7 µm)
paralleled to the modiolus were obtained. After incubation with
3% BSA, cryosections were incubated with diluted primary
antibodies (1:500 mouse anti-TUJ1 (Covance) and 1:200 rabbit
anti-Efr3a (Sigma)) at 4◦C overnight and then were incubated in
1:400 FITC-conjugated donkey anti mouse and 1:400 Alexa-594
conjugated anti-rabbit goat IgG (Beyotime Biotechnology) for
1 h at room temperature. Lastly, the sections were labeled with
DAPI and images were captured using a fluorescent microscope
(Leica, Berlin, Germany). For western blotting, modiolus (not
the intact cochlear organs) in eight cochleae were isolated,
digested and separated for the further experiment.
The Construction of SGNs Degeneration
Model
After genotype analysis, all animals (8–10 weeks old) were
assigned randomly into experimental or control group in both
WT and Efr3a KD mice. The kanamycin and furosemide
treatment was the same as previously described (Nie et al., 2015).
Briefly, experimental animals were treated with a hypodermic
injection of kanamycin (1000 mg/kg) and followed with a
peritoneal injection of furosemide (400 mg/kg) 30–45 min after.
All the experimental mice were divided into the 1st, 5th, 15th,
30th and 60th day groups after injection. Mice administered with
same volume of saline were used as controls.
Auditory Brainstem Response Testing
Auditory brainstem response (ABR) was carried out at the
3rd day before any injection (baseline measurement) and 5th,
15th and 60th day following the kanamycin and furosemide
administration or saline injection (post measurement) in order
to determine the ABR threshold shifts. It was tested using
a MEB-3102 physiological response recorder (Nihon Kohden,
Japan) as previously reported (Nie et al., 2015). Briefly, mice were
anesthetized with ketamine (100 mg/kg) and xylazine (10 mg/kg)
and kept in a sound-proof room during the test. The active
electrode was inserted into the subcutaneous tissue of vertex,
the reference electrode into the mastoid process, and the ground
electrode into the contralateral thigh. Acoustic signal stimuli,
consisting of pure tone bursts at frequencies of 4, 8, 12, 16,
24 and 32 kHz, were generated with Tucker Davis Technologies
device (SigGen) with a rate of 21.1 times per second. For each
test, 512 responses for every frequency were recorded and the
evoked potentials were filtered with a bandpass of 100–3000 Hz.
Stimuli started at 70 dB for the pretreatment groups and at 110 dB
for the post-treatment groups, and decreased by 5 dB until the
threshold was reached. The threshold was determined as the
lowest intensity that wave III could be recorded repeatedly.
Preparation of Cochlear Tissue
Mice cochleae were harvested at the 1st, 5th, 15th, 30th and 60th
day after drugs administration. The animals were euthanized
with overdose of chloral hydrate and both cochleae were
dissected out. Then the cochleae were perfused and fixed in 4%
phosphate buffered paraformaldehyde (pH7.5) overnight at 4◦C
and then decalcified in 10% ethylene diamine tetraacetic acid
(EDTA) at room temperature for 1 week.
Hair Cell Counting
The organ of Corti was carefully separated into apex turn
and base turn. Immunohistochemistry for myosin VIIa were
performed to evaluate cochlear hair cells. The detail procedure
was carried out following the method described previously (Nie
et al., 2015). The tissues were incubated in rabbit anti-myosin
VIIa antibody (1:300; Proteus Bioscience) at 4◦C overnight
and then were incubated with Alexa-594 conjugated anti-rabbit
goat IgG (1:400; Beyotime Biotechnology) for 1 h at room
temperature. Afterwards, the basilar membranes were fixed on
glass slides with antifade solution and images were acquired with
a confocal fluorescent microscopy (Zeiss LSM710).
SGNs Density Counting
After dissecting the bulla, the cochleae were perfused with 2.5%
glutaraldehyde and fixed at least 2 h, decalcified with EDTA for
7 days and then embedded in Eponate 12. The detail protocol
was performed by following the procedure described previously
(Nie et al., 2015). Serial sections (1 µm thick) approximately
parallel to the modiolus were obtained to count the density
of SGNs. Altogether, six cross-sections from Rosenthal’s canal
with an interval approximately 30 µm were taken from each
cochlea. All sections were observed under a lightmicroscope after
staining with 1% toluidine blue. The SGN counts were calculated
including apical, middle and basal turns. NIH Image J software
was used to determine the cross-sectional area of Rosenthal’s
canal. SGN density was calculated by dividing the number
of perikaryon by the cross-sectional area. Five cochleae were
included in each group.
Transmission Electron Microscopy
Ultrathin (50–60 nm) sections parallel to the modiolus were
prepared to study the ultrastructural morphology of SGNs.
Sections were stained sequentially with uranyl acetate and lead
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citrate, and images were captured under a transmission electron
microscope (TEM; Philips CM-120). The morphology of SGN
was detected in the cochlea basal turn, a location where the
influence of hair cell loss on SGN density is obvious.
Based on the close inspection of SGN from WT and
KD cochleae, perikaryal area and cell circularity, two cellular
characteristics of the SGN were selected for quantitative analysis.
One hundred to one hundred and fifty cochlear SGNs with an
obvious nucleus in three mice were counted and measured in
each group. The perikaryal area and circularity were measured
by NIH Image J software. The ultrastructural changes of
the mitochondrial and endoplasmic reticulum morphology,
lipofuscin-like granule in perikaryon were also observed. In
addition, quantitative analysis of lipofuscin-like granules was
performed by measuring the ratio of lipofuscin area/SGN
cytoplasm area (excluding the nucleus).
Quantitative Real Time PCR and Reverse
Transcription PCR
Total RNA of the modiolus including spiral ganglia from the
same brood of control WT and Efr3a KD mice at 8-week old
was prepared using TRIzol reagent (Takara Bio Inc., Japan).
Total RNA was further purified using DNase I to eliminate
contaminating genomic DNA, then the cDNA was synthesized
using the PrimeScriptTM RTMasterMix (Takara Bio Inc., Japan).
A portion of the cDNAs was used as template for the real-time
PCR, which were carried out with the ABI PRISM 7500 System
(Thermo Fisher Scientific) using SYBRr Premix Ex TaqTM (Tli
RNaseH Plus; Takara Bio Inc. Japan). The primer sequences
of targeted genes are listed below. The relative concentration
of targeted genes relative to GAPDH was determined by the
2(−∆∆CT) method. Then, another portion of the cDNAs was used
for normal PCR, and the PCR products were identified with 3%
agarose gel electrophoresis. The gray intensity of detected bands
was quantified using Image Lab software (v 5.2; Bio-Rad, USA)
and normalized them against the density of GAPDH.
• Neural growth factor (NGF):
5′ TCCACCCACCCAGTCTTCCA 3′ (forward)
5′ CCTTCCTGCTGAGCACACA 3′ (reverse)
• BDNF:
5′ GCGGCAGATAAAAAGACTGC 3′ (forward)
5′ CTTATGAATCGCCAGCCAAT 3′ (reverse)
• NT-3:
5′ CTACTACGGCAACAGAGACGCT 3′ (forward)
5′ GGTGAGGTTCTATTGGCTACCAC 3′ (reverse)
• Tyrosine kinase receptor A (TrkA):
5′ ACGGTAACAGCACATCAAGAG 3′(forward)
5′ GGAGGGCAGAAAGGAAGAG 3′(reverse)
• Tyrosine kinase receptor B (TrkB):
5′ AAGGACTTTCATCGGGAAGCTG 3′(forward)
5′ TCGCCCTCCACACAGACAC 3′(reverse)
• Tyrosine kinase receptor C (TrkC):
5′ CAACTCTCAAACACGGAGGTC 3′(forward)
5′ CCAGCATGACATCGTACACC 3′(reverse)
• GAPDH:
5′ GGTGAAGGTCGGTGTGAACG 3′ (forward)
5′ CTCGCTCCTGGAAGATGGTG 3′ (reverse)
Western Blotting
The 8-week old WT and Efr3a KD mice were sacrificed and the
modiolus including spiral ganglia were rapidly isolated from the
cochleae. The protein was extracted as reported previously (Nie
et al., 2015). Tissues were lysed in radio immunoprecipitation
assay buffer (Beyotime) and homogenized, then subjected
to western blotting analysis. Protein were separated by 12%
SDS-PAGE gels for 120–150 min at 80 V and transferred onto
polyvinylidene fluoride (PVDF) membranes (Millipore, USA).
The membranes were blocked with 5% skim milk in TBST for
1 h at room temperature and incubated with primary antibodies
for TrkA (Abcam, USA; 1:1000), TrkB (CST, USA; 1:1000), TrkC
(CST, USA; 1:1000), NGF (Abcam, USA; 1:1000), BDNF (Sigma,
USA; 1:1000), NT-3 (Santa Cruz, USA; 1:1000) and β-actin
(Beyotime, 1:1000) overnight at 4◦C, and then incubated with
HRP-conjugated secondary antibody for 1 h at room temperature
after being washed three times in TBST. The immunoreactive
signals were detected using enhanced chemiluminescence system
with BeyoECL Star kit (Beyotime Biotechnology) and the bands
were semi-quantified using Image Lab software (v 5.2; Bio-Rad,
USA).
Statistical Analysis
The SPSS statistical software (v 19.0; SPSS Inc., Chicago, IL,
USA) was used for all statistical analysis. Distributions of
all data in each group were analyzed for normality using
the Shapiro-Wilk test. Group comparisons between WT and
KD mice at the same time point were made using Student’s
t-test or Mann-Whitney test. Statistically significant differences
of perikaryal area, circularity and lipofuscin area between
experimental and control mice within WT and KD mice were
determined via one-way ANOVA testing followed by Dunnett
post hoc testing. A p-value of <0.05 was deemed to indicate
statistical significance.
RESULTS
Time Course Analysis of Auditory
Brainstem Response in Efr3a Knockdown
and Wild Type Mice Subjected to
Kanamycin and Furosemide Treatment
Unconditional Efr3a knockout mice (Efr3a−/−) are embryonic
lethal. Thus, we used Efr3a−/+ heterozygotes, here named as
Efr3aKDmice, for the following experiments. We first examined
the expression level of Efr3a protein in Efr3a KD mice and
their WT littermates. Immunofluorescence staining in the frozen
sections showed that, compared withWTmice, the expression of
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FIGURE 1 | Eighty-five requiring 3a knocking down (Efr3a KD) ameliorated the hearing loss induced by kanamycin and furosemide treatment.
(A) Representative fluorescent immunohistochemistry images of Efr3a protein in the spiral ganglion neurons (SGNs), repeated at least three times, scale
bar = 50 µm; (B) representative western blot (top) and semi-quantification (bottom) showing the Efr3a expression in the spiral ganglion of cochlea, n = 8 for wild type
(WT) and Efr3a KD, respectively. T-test, unpaired, two tail; (C) mean auditory brainstem response (ABR) thresholds to sound stimulations at different frequencies. KD
and WT represent Efr3a KD and WT mice without drug treatment respectively, while KD-5d and WT-5d represent Efr3a KD and WT mice with drugs treatment at the
5th day posterior to drugs application respectively. n = 16 for each data point, Mann-Whitney test or unpaired T-test, following normality test; Data are represented
by mean ± SEM, “∗” indicates p < 0.05 between Efr3a KD and WT mice at the same frequency.
Efr3awas obviously decreased in the Efr3aKDmice (Figure 1A).
Consistently, quantitative analysis of Efr3a protein in cochlea by
western blotting showed an intense band from the cochleae of
WT mice, but a weaker band from the cochleae of KD mice
at 92.5 kDa position, the expression of Efr3a was decreased by
approximately 50% (p < 0.05) in the Efr3a KD mice, confirming
the reduction of Efr3a in Efr3a KDmice (Figure 1B).
Then, a time course analysis of the effect of Efr3a KD on
the hearing impairment induced by kanamycin and furosemide
treatment through measuring the ABR threshold was conducted.
Total 16 Efr3a KD mice and 16 WT were used. Before
drugs treatment, the hearing function observed in both WT
and Efr3a KD mice are similar to that previously described
for C57BL/6J (Park et al., 2010; Mistry et al., 2014; Xiong
et al., 2014), the ABR thresholds at pure tones of 4, 8,
12, 16, 24 and 32 kHz frequencies between the two groups
were indistinguishable (Figure 1C, bottom), indicating partial
deletion of Efr3a did not significantly change the function
of the auditory system. Five days after drugs treatment, the
ABR thresholds in both groups were markedly increased,
demonstrating a severe hearing loss in both groups. Interestingly,
the ABR thresholds in KD mice were relatively lower than
those in WT mice, especially at 8 kHz (91.56 ± 2.95 dB vs.
81.56 ± 2.27 dB, t test, p = 0.012) and 12 kHz (91.56 ± 2.80 dB
vs. 81.25 ± 1.96 dB, t test, p = 0.005; Figure 1C, top).
Fifteen and 60 days after drugs treatment, however, the ABR
thresholds at all six frequencies in almost all animals were higher
than 85 dB, and no significant difference of ABR thresholds
between WT and KD mice was observed, which might be
due to the loss of vast majority of hair cells in both strains
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FIGURE 2 | Efr3a reduction did not change the loss of hair cells caused by drugs treatment Representative myosin VIIa immuno-labeled hair cells in the
cochleae of the WT (WT) and Efr3a KD (KD) mice without drug treatment (A) and with drugs treatment at the 5th day (B), scale bar = 50 µm. (C) Quantification of
VIIa immuno-labeled hair cells in non-treated (control) and drug-treated WT and KD mice at the 1st, 5th, 15th and 30th day posterior to drugs application, n ≥ 5 for
each data point. Data are represented by mean ± SEM. No significant difference in density of hair cells in both apical and basal turns of cochlea between Efr3a KD
and WT mice were observed.
of mice (Figure 2). Nevertheless, the data demonstrate that
Efr3a reduction temporarily ameliorated the hearing impairment
caused by kanamycin and furosemide.
Efr3a Reduction did Not Change the Loss
of Hair Cells Caused by Drugs Treatment
We conducted immunofluorescence staining in whole mounts of
the Corti organ with an antibody against Myosin VIIa to label
hair cells in both Efr3a KD and WT mice with and without drug
treatment. As shown in Figures 2A,C, the density, morphology
and arrangement of hair cells in both groups without drug
treatment were indistinguishable, indicating Efr3a KD did not
affect the development of hair cells. We also did a time course
analysis of the density of hair cells in both groups of mice with
drugs treatment at the 1st, 5th, 15th and 30th day after drugs
administration. Starting from the 1st day, a progressive severe
loss of hair cells occurred in both groups (Figures 2B,C). The
density of inner hair cells (IHCs) in both apical and basal cochlea
was reduced by about 50% at the 1st day, followed by about 50%
decrease in the density of residual hair cells by the 5th day, and a
further 50% reduction by the 15th day, then no further obvious
loss of hair cells. The destruction of outer hair cells (OHCs) was
faster and severer than the IHCs, more than 70% by the 1st day,
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and almost complete loss by the 15th day. At each time point
posterior to drugs treatment, there was no significant change in
density of residual inner or OHCs in both apical and basal turns
of cochlea between Efr3a KD andWT mice (Figure 2C).
Efr3a Reduction Suppressed SGN
Degeneration Following Hair Cell Loss
Hair cells are innervated by the SGNs, which are known to
degenerate over time following the loss of hair cells. To test
whether Efr3a reduction could produce a protective role against
the SGN degeneration, we conducted toluidine blue staining and
light imaging, then quantitative analysis of the densities of SGNs
in Rosenthal’s canal at the 5th, 15th, 30th and 60th day following
drugs administration. We counted SGNs in the apical, middle
and basal regions of Rosenthal’s canal. At the 5th day posterior
to the drugs administration, the densities of SGN in both WT
and Efr3aKDmice did not change significantly, but progressively
decreased to much lower values at the following time points,
45% in WT and 53% in KD group in the apical turn at the
60th day (t test, p = 0.026; Figure 3A); 51% in WT and 61% in
KD group in the middle turn at the 60th day (t test, p = 0.008;
Figure 3B); 69% in WT and 76% the in KD group in the basal
turn at the 30th day (t test, p = 0.002) and 49% in WT and 57%
in KD group in the basal turn at the 60th day (t test, p = 0.026;
Figure 3C).
FIGURE 3 | Efr3a reduction attenuated the loss of SGNs caused by drugs treatment. Serial light microscopy changes of the SGNs from WT mice vs. Efr3a
KD mice from apical (A), middle (B) and basal (C) regions of the cochlea, scale bar = 100 µm. The quantification of the SGN densities in each region is shown at the
right. SGN density showed a progressive decrease in both strains, but earlier and more severe in WT mice (A–C). Data are represented by mean ± SEM, n = 5 for
each data point, T-test, unpaired, two tail; “∗” indicates p < 0.05.
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FIGURE 4 | Efr3a reduction ameliorated the structural alterations of SGNs following hair cell loss. Representative transmission electron microscope (TEM)
images of the SGNs in the cochlea from WT and Efr3a KD (KD) mice without (A1,B1) and with drugs treatment at the 15th (A2,B2), 30th (A3,B3) and 60th (A4,B4)
day posterior to drugs application. (C1–C4) is a close view of the boxed areas in (A1,B1,A2,B2) respectively. White arrows indicate the cytoplasmic vacuoles
gathered at the edge of the cytoplasm of the SGNs, with a few swelling and scattered mitochondria (m), while black arrows indicate the balloon-like appearance
around the perikarya of SGNs. Scale bar = 5 µm in (A1–A4) and (B1–B4). Quantitative time-course analysis of the perikaryal area (D1) and cell circularity (D2). Data
are represented by mean ± SEM, n ≥ 100 SGNs for each data point, unpaired T-test (two tail) or Mann-Whitney test between WT and KD group at the same time
point, and one-way ANOVA testing followed by Dunnett post hoc testing between experimental and control group within WT and KD mice. Blue “∗” indicates
p < 0.05 compared with control in Efr3a KD mice, red “∗” indicates p < 0.05 compared with control in WT mice, and black “#” indicates p < 0.05 between Efr3a KD
and WT mice in each time point. WT vs. Efr3a KD: p = 0.038 at the 60th day for perikaryal area, p = 0.026 at the 15th day and p = 0.018 at the 30th day for cell
circularity.
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We further studied the SGN degeneration with TEM. The
TEM images of SGNs were taken from the cochlear basal turn,
where the effect of hair cell loss on SGN density is most
prominent. In WT and Efr3a KD mice without drug treatment,
several SGNs lie typically close to each other, intracellular
organelles, such as mitochondria, are intact, chromatin is
distributed evenly in the prominent nucleus and the perikaryon
is surrounded by the myelin sheath of the peripheral process
of a Schwann cell (Figures 4A1,B1,C1,C2). However, drugs
treatment induced a series of time-dependent intracellular
changes in the SGNs in both WT and Efr3a KD mice.
At the 5th day, similar to our previous report (Nie et al.,
2015), the perikarya of only few neurons were slightly or
moderately enlarged (data not shown) in both WT and Efr3a
KD mice. At the 15th day, the perikarya further enlarged,
abnormal mitochondria with rarefaction of the matrix and
partial loss of cristae as well as cytoplasm vacuolization became
evident, lipofuscin accumulated, and the cell body of SGNs
deformed (reflected by the change in cell circularity) in both
WT mice and Efr3a KD mice, but more severe in WT mice
(Figures 4A2,B2,C3,C4,D1,D2, 5A,B). At 30th day and 60th
day, the perikarya shrinked gradually, and other degenerative
changes became more and more severe in both WT mice
and Efr3a KD mice, and largely more severe in WT mice
(Figures 4A3,B3,A4,B4,D1,D2, 5A,B). These data demonstrate
that Efr3a reduction reduced the drug-induced degeneration in
SGNs.
Efr3a Reduction Increased the Expression
of Some Neurotrophic Factors and their
Receptors
Lack of target-derived neurotrophic factors has been suggested
and tested to explain the dying back process of neurons.
Given the report that the expression of BDNF and its receptor
TrkB was found to be increased in the brain of mice with
nestin-CRE mediated complete knockout of Efr3a (Qian et al.,
2017), Quantitative real-time PCR was performed to examine
the mRNA of NGF, BDNF, NT-3 and their receptors, TrkA,
TrkB and TrkC, in the spiral ganglions from the same brood of
control WT and Efr3a KD mice without drug treatment. Indeed,
the mRNA levels of BDNF and NT-3 and their receptors, but
not NGF and TrkA, were significantly elevated in Efr3a KD
mice (Figure 6A). Then we re-confirmed the changes by reverse
FIGURE 5 | Efr3a reduction suppressed the formation of lipofuscin in SGNs following hair cell loss. (A) Representative TEM images showing lipofuscin-like
granule (black arrow) in the perikarya of SGNs. Scale bars = 2 µm. (B) Quantitative time-course analysis of the ratio of lipofuscin area/SGN cytoplasm area
(excluding the nucleus). Data were represented by mean ± SEM, n ≥ 50 SGNs for each data point, unpaired T-test (two tail) between WT and KD group at the same
time point, and one-way ANOVA testing followed by Dunnett post hoc testing between experimental and control group within WT and KD mice. Blue “∗” indicates
p < 0.05 compared with control in Efr3a KD mice, red “∗” indicates p < 0.05 compared with control in WT mice, and black “#” indicates p < 0.05 between Efr3a KD
and WT mice in each time point. WT vs. Efr3a KD: p = 0.043 at the 15th day and p = 0.045 at the 60th day.
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FIGURE 6 | Efr3a reduction upregulated the expression of some neurotrophins and their receptors at mRNA levels. Quantification of the mRNA levels of
brain-derived neurotrophic factor (BDNF), neurotrophins-3 (NT-3), tyrosine kinase receptor B (TrkB) and tyrosine kinase receptor C (TrkC) in WT and Efr3a KD mice by
real-time polymerase chain reaction (PCR; A) and reverse transcription (RT)-PCR (B,C), the representative images of the electrophoresis of RT-PCR products are
shown in (B). Data are represented by mean ± SEM, n = 8, T-test, unpaired, two tail. “∗” indicates p < 0.05 between Efr3a KD and WT mice.
transcription PCR (RT-PCR) and electrophoresis, and found
similar elevation in BDNF,NT-3, TrkB and TrkC (Figures 6B,C).
Further more, the protein levels of BDNF, NT-3 and TrkB, but
not NGF, TrkA and TrkC, in Efr3a KD mice were higher than
those in WT mice (Figure 7).
DISCUSSION
Aminoglycoside antibiotics have substantial ototoxic effects. A
single dose injection of aminoglycoside immediately following
by injection of a loop diuretic induces hair cell loss rapidly, and
subsequent progressive degeneration of SGNs and their auditory
nerve fibers in chinchilla, rats, guinea pigs and mice at relatively
slower speed, which have been frequently used to model the
disease of SNHL for studying disease mechanism and therapeutic
efficacy (McFadden et al., 2004; Glueckert et al., 2008; Layman
et al., 2015; Wang et al., 2015). In the present study, we, with the
co-administration of a single dose of kanamycin and furosemide,
successfully and rapidly destroyed vast majority of cochlear hair
cells by 15 days, consequently induced a progressive degeneration
of SGNs in mice with a similar time course as reported in the
previous studies. At the 5th day after drugs administration, WT
animals developed a severe hearing impairment, at 15th day the
ABR thresholds at all frequencies were higher than 85 dB, and
remained high until the 60th day. In parallel to the hearing
loss, there was a progressive loss of IHCs: about 50% IHCs
disappeared by the 1st day, followed by 50% reduction of the
residual IHCs by the 5th day, a further 50% reduction by the
15th day, then not much change during the 15th–30th days. The
loss of OHCs was relatively faster and more severe, over 70%
loss by the 1st day, and almost complete loss by the 15th day.
Consequently, starting from the 5th day, the SGNs degenerated
FIGURE 7 | Efr3a reduction upregulated the expression of some neurotrophins and their receptors at protein levels. The representative immunoreactive
bands and quantification of the protein levels of neural growth factor (NGF), BDNF, NT-3, tyrosine kinase receptor A (TrkA), TrkB and TrkC in WT and Efr3a KD mice
by western blotting. Data are represented by mean ± SEM, n = 12, T-test, unpaired, two tail. “∗” indicates p < 0.05 between Efr3a KD and WT mice.
Frontiers in Molecular Neuroscience | www.frontiersin.org 10 March 2017 | Volume 10 | Article 86
Hu et al. Efr3a Insufficiency Reduces SGN Degeneration
over time, and the ultrastructure of SGNs underwent stereotypic
degenerative changes in the perikarya, intracellular organelles,
cell body conformation.
Efr3a KD temporarily suppressed the rapid loss of hearing
ability, and the progressive and relatively slower degenerative
alterations in SGNs in the model of hearing loss, indicating Efr3a
KD produced a beneficial effect against the neurodegeneration
of SGNs induced by aminoglycoside antibiotics. Moreover, Efr3a
KD significantly increased the expression of BDNF, NT-3 and
their receptors, TrkB and TrkC at both mRNA and protein levels,
but not the expression of NGF and TrkA, which is consistent with
a recent study that complete knockout of Efr3a in brain neurons
elevated the expression levels of BDNF and TrkB, and suppressed
the apoptosis of hippocampal newborn neurons in adult mice
(Qian et al., 2017).
Neurotrophic factors and their tyrosine kinase receptors play
essential roles in the establishment of neuron number through
their control of cell survival/death during neuronal development
and degeneration (Huang and Reichardt, 2001; Schimmang
et al., 2003; Ito and Enomoto, 2016). The degeneration of SGN
in SNHL was considered to be a consequence of absence of
neurotrophic factor from the hair cells, which is supported by
many other studies showing that the ultrastructural changes and
loss of SGNs in SNHL could be attenuated by the application
of BDNF or NT-3 (Staecker et al., 1996; Richardson et al.,
2005; Shepherd et al., 2005; Agterberg et al., 2008; Landry et al.,
2011; Fukui et al., 2012; van Loon et al., 2013). In addition,
previous studies showed that Efr3a expression was up-regulated
in the lateral superior olive within 2 days after the removal of
cochleae (Munemoto et al., 2004) and in SGNs within 5 days
after the co-administration of kanamycin and furosemide (Nie
et al., 2015). Therefore, we speculate that Efr3a may negatively
regulate the expression of NT-3, BDNF, TrkB and TrkC, and the
beneficial effect of Efr3a KD might be ascribed to an elevation of
the corresponding downstream signalings.
It is well known that Efr3/RBO forms a plasma membrane
localized complex with PI4KIIIα and a scaffold protein to
maintain the levels of plasmalemmal PI4P and PI4,5P, particularly
PI4P (Baird et al., 2008; Hammond et al., 2012; Nakatsu
et al., 2012). Whether and how this protein complex regulates
the expression of neurotrophins and their receptors, and
in turn regulates the down-stream signalings by controlling
plasmalemmal levels of PI4P and PI4,5P remain to be determined.
Except at a narrow window of stimulating frequencies and at
the 5th day after drugs treatment, there was a close correlation
between ABR thresholds and the densities of SGNs and hair cells
in WT and Efr3a KD mice at all stimulating frequencies and
at all the days thereafter. The explanation could be that at the
5th day, the functional state of SGNs and hair cells with higher
levels of neurotrophins in Efr3a KD mice was better than that in
WT mice. Efr3a KD produced moderate beneficial effect on the
survival of SNGs, but not on that of hair cells. The explanation
is that the detrimental effect of ototoxic drugs at high dose on
the preservation of hair cell density was too strong be suppressed
by the beneficial effect of Efr3a insufficiency due to the higher
susceptibility of hair cells to the drugs than SGNs and other
cells in the body. Nevertheless, the functional state of hair cells
with higher levels of neurotrophins in Efr3a KD mice might be
still better than that in WT mice at the 5th days after drugs
injection. Therefore, under sound stimulation at a narrow range
of frequencies at the 5th day after drugs application, the ABR
thresholds in Efr3a KD mice were significantly lower than those
in WT mice.
Taken together, our study indicated that decrease of Efr3a
attenuates the degeneration of SGN after hair cell loss, possibly
by up-regulating the expression of some neurotrophic factors and
their receptors.
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